Global intraoperative neuromonitoring market size is expected to reach $4.88 Bn by 2028 at a rate of 7.5%, segmented as by products and services, systems, accessories, services
The market is majorly driven by the augmenting focus on patient safety during complex surgical procedures. This can be attributed to a considerable rise in the prevalence of chronic neurovascular disorders, such as epilepsy, stroke, Parkinson’s disease and Alzheimer’s disease For an Executive Summary of Intraoperative Neuromonitoring (IONM) Report Visit the following link: https://www.imarcgroup.com/intraoperative-neuromonitoring-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
The market is majorly driven by the augmenting focus on patient safety during complex surgical procedures. This can be attributed to a considerable rise in the prevalence of chronic neurovascular disorders, such as epilepsy, stroke, Parkinson’s disease and Alzheimer’s disease For an Executive Summary of Intraoperative Neuromonitoring (IONM) Report Visit the following link: https://www.imarcgroup.com/intraoperative-neuromonitoring-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
The rising prevalence of chronic diseases, increasing geriatric population, applications of intraoperative neuromonitoring in different surgeries, and use of intraoperative neuromonitoring for risk management during complex surgeries are the key factors leading to the growth of the market.
The intraoperative neuromonitoring market is expected to reach US$ 4,199.95 million in 2027 from US$ 2,341.92 million in 2019. The market is estimated to grow with a CAGR of 7.6% from 2020 to 2027.
IONM systems are used to monitor the central nervous system (CNS) and alert the surgeons before an individual reaches the threshold for injury, hence they play a vital role by emphasizing the safety of the patient. This focus on patient safety is one of the major factors contributing to the growth of the market. These systems also play a crucial role during serious surgeries such as spinal surgeries that involve the insertion of instruments near the nerves or the spinal area and may cause damage to the CNS. Know More @ http://www.bigmarketresearch.com/intraoperative-neuromonitoring-in-the-us-2016-2020-market
The Global And China Intraoperative Neuromonitoring (IONM) Devices Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Intraoperative Neuromonitoring (IONM) Devices industry.
Big Market Research has announced a new Report Package "Intraoperative Neuromonitoring Market in the US -Size, Share, Trends, Forecast,Development, Situation, Future outlook, Potential" Get Complete Details At: http://www.bigmarketresearch.com/intraoperative-neuromonitoring-in-the-us-2015-2019-market Intraoperative neuromonitoring (IONM) technology involves the use of IONM devices to assess the function of the nerves and spinal cord during surgeries. It can be used in various surgical procedures including neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, cardiac surgery, genitourinary surgery, interventional radiological procedures, and other general surgeries. Enquire About This Report at: http://www.bigmarketresearch.com/report-enquiry/169898
The global epilepsy devices market is expected to reach $1203.70 million by 2030, growing at a CAGR of 7.83% during the forecast period 2022-2030. Read More.
Hyperthyroidism is a condition in which an overactive thyroid gland is producing an excessive amount of thyroid hormones, such as thyroxine and triiodothyronine that circulate in the blood. Common symptoms of hyperthyroidism include restlessness, agitation, anxiety, weight loss despite increased appetite, intolerance to heat and frequent bowel movements among others.